Home

Argenica Therapeutics (ASX: AGN) - Webinar Presentation

PUBLISHED

2023-04-17

Content

Liz Dallimore - CEO & Managing Director - Argenica Therapeutics is developing novel neuroprotective therapeutics to reduce brain damage after stroke.